Preliminary results were reported from a randomized trial in which patients with TRN MBC refractory to between one and three lines of chemotherapy were randomly assigned to carboplatin plus cetuximab versus cetuximab alone 54 <a href=
https://lasix.beauty>buy lasix online cheap</a> Nielsen TO, Parker JS, Leung S, Voduc D, Ebbert M, Vickery T, et al